Serveur d'exploration sur le lymphœdème - Curation (Ncbi)

Index « Mesh.i » - entrée « Cost-Benefit Analysis »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cost of Illness < Cost-Benefit Analysis < Costs and Cost Analysis  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 36.
[0-20] [0 - 20][0 - 36][20-35][20-40]
Ident.Authors (with country if any)Title
000120 (1999) W. Döller [Autriche][Current status of therapy of lymphedema in Austrian hospitals--a comprehensive Austrian survey].
000266 (2000) A. Srividya [Inde] ; R. Lall ; K D Ramaiah ; K. Ramu ; S L Hoti ; S P Pani ; P K DasDevelopment of rapid assessment procedures for the delimitation of lymphatic filariasis-endemic areas.
000C67 (2002) K. Krishnamoorthy [Inde] ; R. Rajendran ; I P Sunish ; R. ReubenCost-effectiveness of the use of vector control and mass drug administration, separately or in combination, against lymphatic filariasis.
001A93 (????) Els Mathieu [États-Unis] ; Michael Deming ; Patrick J. Lammie ; Steven I. Mclaughlin ; Michael J. Beach ; Domingue J. Deodat ; David G. AddissComparison of methods for estimating drug coverage for filariasis elimination, Leogane Commune, Haiti.
001B76 (2004) Kapa D. Ramaiah [Inde] ; Pradeep K. DasMass drug administration to eliminate lymphatic filariasis in India.
001E42 (2005) B V Babu [Inde]A rapid method to assess the coverage of the mass drug administration of diethylcarbamazine in the program to eliminate lymphatic filariasis in India.
002249 (????) Denise Hardy [Royaume-Uni]Managing long-term conditions: non-cancer-related lymphoedema.
002363 (2006) P. Vanamail [Inde] ; S. Subramanian ; A. Srividya ; R. Ravi ; K. Krishnamoorthy ; P K DasOperational feasibility of lot quality assurance sampling (LQAS) as a tool in routine process monitoring of filariasis control programmes.
002C01 (2008) A. Eigege [Nigeria] ; E. Pede ; E. Miri ; J. Umaru ; P. Ogbu Pearce ; M Y Jinadu ; A N NjepuomeTriple drug administration (TDA), with praziquantel, ivermectin and albendazole, for the prevention of three neglected tropical diseases in Nigeria.
002F54 (2008) Caroline Chanussot-Deprez [Mexique] ; José Contreras-RuizTelemedicine in wound care.
003B60 (2010) Brian K. Chu [États-Unis] ; Pamela J. Hooper [États-Unis] ; Mark H. Bradley [Royaume-Uni] ; Deborah A. Mcfarland [États-Unis] ; Eric A. Ottesen [États-Unis]The Economic Benefits Resulting from the First 8 Years of the Global Programme to Eliminate Lymphatic Filariasis (2000–2007)
003B99 (2010) Andrea L. Cheville [États-Unis] ; Mously Almoza [États-Unis] ; Janice N. Courmier [États-Unis] ; Jeffrey R. Basford [États-Unis]A Prospective Cohort Study Defining Utilities Using Time Trade-Offs and the Euroqol-5D to Assess the Impact of Cancer-Related Lymphedema
003F81 (2011) Y. Meng [Royaume-Uni] ; S. Ward ; K. Cooper ; S. Harnan ; L. WyldCost-effectiveness of MRI and PET imaging for the evaluation of axillary lymph node metastases in early stage breast cancer.
004158 (2011) Harriet Namwanje [Ouganda] ; Narcis Kabatereine ; Annette OlsenA randomised controlled clinical trial on the safety of co-administration of albendazole, ivermectin and praziquantel in infected schoolchildren in Uganda.
004779 (2011) A.-F. Gabrielli ; A. Montresor ; L. Chitsulo ; D. Engels ; L. SavioliPreventive chemotherapy in human helminthiasis: theoretical and operational aspects
004A27 (2011) Jennifer L. Dine [États-Unis] ; Melanie K Schneider Austin ; Jane M. ArmerNursing education on lymphedema self-management and self-monitoring in a South African oncology clinic.
004B73 (2012) H. Verry [Australie] ; S J Lord [Australie] ; A. Martin [Australie] ; G. Gill [Australie] ; C K Lee [Australie] ; K. Howard [Australie] ; N. Wetzig [Australie] ; J. Simes [Australie]Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis
004C57 (2012) Andrea L. Cheville [États-Unis] ; John A. Nyman ; Sandhya Pruthi ; Jeffrey R. BasfordCost considerations regarding the prospective surveillance model for breast cancer survivors.
004E54 (2012) Sara P. Bilir [États-Unis] ; Mitchell P. Dekoven ; Juliet MunakataEconomic benefits of BIS-aided assessment of post-BC lymphedema in the United States.
005226 (2013) A E Clements [États-Unis] ; B J Tierney ; D E Cohn ; J M StraughnIs selective lymphadenectomy more cost-effective than routine lymphadenectomy in patients with endometrial cancer?
005419 (2012) Clare J. Reade [Canada] ; Waldo Jimenez ; Daria O'Reilly ; Al CovensSentinel lymph node biopsy in vulvar cancer: a health technology assessment for the canadian health care context.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "Cost-Benefit Analysis" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i  \
                -Sk "Cost-Benefit Analysis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Cost-Benefit Analysis
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024